Navigation Links
Immunomedics Announces Preclinical Therapy Results of SN-38 Immunoconjugate for Colorectal Cancer
Date:1/20/2009

s. For additional information on us, please visit our website at www.immunomedics.com. The information on our website does not, however, form a part of this press release.

This release, in addition to historical information, may contain forward-looking statements made pursuant to the Private Securities Litigation Reform Act of 1995. Such statements, including statements regarding clinical trials, out-licensing arrangements (including the timing and amount of contingent payments), forecasts of future operating results, and capital raising activities, involve significant risks and uncertainties and actual results could differ materially from those expressed or implied herein. Factors that could cause such differences include, but are not limited to, risks associated with new product development (including clinical trials outcome and regulatory requirements/actions), our dependence on our licensing partners for the further development of epratuzumab for autoimmune indications and veltuzumab for non-cancer indications, competitive risks to marketed products and availability of required financing and other sources of funds on acceptable terms, if at all, as well as the risks discussed in the Company's filings with the Securities and Exchange Commission. The Company is not under any obligation, and the Company expressly disclaims any obligation, to update or alter any forward-looking statements, whether as a result of new information, future events or otherwise.

    For More Information:
    Dr. Chau Cheng
    Associate Director, Investor Relations & Business Analysis
    (973) 605-8200, extension 123
    ccheng@immunomedics.com

'/>"/>
SOURCE Immunomedics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
2. Kyowa Hakko Kirin Announces Development Policy for Anti-Parkinsons Disease Drug KW-6002 (Istradefylline)
3. Intra-Cellular Therapies Announces Successful Outcome of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia
4. Beactica Announces Fragment-Based Drug Discovery Research Collaboration With GE Healthcare and Uppsala University
5. Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
6. NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
7. Pulmo BioTech Inc. Announces Dual Listing on Frankfurt Borse
8. Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference
9. Anesiva Announces FDA Approval of Supplemental New Drug Application to Expand Zingo(TM) Indication
10. ProUroCare Medical Inc. Announces Pricing of Equity Offering
11. Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... NORTHBROOK, Ill. , Sept. 16, 2014 /PRNewswire/ ... a new director of Business Communications & Advocacy, ... Vice President, Business Communications & Advocacy Margaret Long. In ... Astellas, commitment to urology to patient and advocacy ... brand teams on key strategic initiatives. Noland,s appointment ...
(Date:9/16/2014)... KANSAS CITY, Kan. , Sept. 16, 2014 ... ), a pet therapeutics company focused on licensing, ... animals, today announced that it is commencing an ... common stock.  All of the shares are being ... LLC and Barclays are acting as joint book-running ...
(Date:9/16/2014)... 2014 /PRNewswire-iReach/ -- Dan York has been ... of the RTD ® Advanced Wound Care Dressing, ... sales presence in the U.S. Under York,s leadership, GWM ... field sales representatives in new sales territories that will ... add up to 20 sales representatives in major metropolitan ...
Breaking Medicine Technology:Christy Noland to Lead Urology Advocacy and Communications for Astellas 2Aratana Therapeutics, Inc. Announces Proposed Public Offering 2GWM Products, LLC, announces U.S. market expansion. Dan York added as Director of Sales as part of nationwide growth initiative. 2
... Epiphany Biosciences announced,today, the initiation of a Phase ... and management of acute infectious,mononucleosis. Currently, there are ... condition or any other disease caused by,the Epstein-Barr ... spectrum of anti-viral activity,including inhibition of viral replication ...
... 6 Some 5,000 COPD patients will be ... (Alpha-1) in,a study marking a major cooperative effort ... Respiratory Care (AARC)., The principal investigator is ... Pulmonary Medicine, National Jewish Medical and Research Center,in ...
Cached Medicine Technology:Epiphany Biosciences Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis 2Alpha-1 Foundation, AARC Cooperate on Study to Test 5,000 COPD Patients for Alpha-1 2Alpha-1 Foundation, AARC Cooperate on Study to Test 5,000 COPD Patients for Alpha-1 3
(Date:9/17/2014)... (PRWEB) September 17, 2014 Kristen Yarker, MSc, ... the parents of children 9 months to 2 years old ... and furthermore, prevent picky eaters from developing by encouraging healthy ... Eating (9 months to 2 years): How to Transition From ... Child Is Getting the Nutrition They Need)” is a new ...
(Date:9/17/2014)... September 17, 2014 Angeldress.co.uk ... of graceful special occasion outfits for worldwide clients. According ... are thinking of opening the first flagship retail store. ... industry. Recently, the company has unveiled its new range ... , All its new products are offered at ...
(Date:9/17/2014)... Calif. (PRWEB) September 17, 2014 ... monthly interruptions, giving girls of all ages an ... wellness company founded by women, for women, announces ... Uninterrupted® (http://GirlU.com) to relieve the symptoms ... bloating and irritability. , As a lifelong ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 In a ... Diego, Dr. William Groff, an expert on the condition known ... Pearly penile papules , or PPP, is a condition ... although other men may be affected as well. The condition ... penis. , “While PPP is not a sexually transmitted ...
(Date:9/17/2014)... A raucous childhood in an Italian-Polish family and ... Nancy Chovancek’s laughter-filled new book, “Angry Birds and Beehive ... stories that prove the best way to deal with ... of empowerment and resilience, everyone can identify with Chovancek’s ... two books under her belt on the topic of ...
Breaking Medicine News(10 mins):Health News:Nutritionist Kristen Yarker Offers Parents a Fresh Approach to Prevent Picky Eaters in New Online Seminar 2Health News:Nutritionist Kristen Yarker Offers Parents a Fresh Approach to Prevent Picky Eaters in New Online Seminar 3Health News:Angeldress.co.uk Is Planning To Open Its First Retail Store And Offering Big Savings On Amazing Wedding Dresses 2Health News:Girl Uninterrupted® Debuts New Look for All-Natural, PMS-Relief Supplement, Launching Today 2Health News:Girl Uninterrupted® Debuts New Look for All-Natural, PMS-Relief Supplement, Launching Today 3Health News:Girl Uninterrupted® Debuts New Look for All-Natural, PMS-Relief Supplement, Launching Today 4Health News:New Video Depicts Best Treatment for PPP 2Health News:New Video Depicts Best Treatment for PPP 3
... genetic risk factors for rheumatoid arthritis (RA) have ... identified so far have been associated with autoantibody-positive ... but distinguishing this variant from autoantibody-negative RA, which ... A new study led by Diane van der ...
... tips from spinal experts helps professionals get back to ... professionals logging long hours at their desks, it,s not ... to Americans suffering from back pain.* This Administrative Professionals ... is helping administrative support professionals find relief. Simple ...
... Expertise to National OrganizationSPRINGFIELD, Va., April 7 ... organization dedicated to supporting those affected by the ... has selected Christine Brown to be its first ... management, program development, fundraising and advocacy relations to ...
... respondents say , , TUESDAY, April 7 (HealthDay News) -- Flavored ... and should carry warning labels, say many American adults who ... sweet drinks made to taste like cola or soda pop ... 8 percent alcohol content, which is a little bit more ...
... LAKE CITY University of Utah researchers have found ... predicting treatment outcomes and measuring disease progression for patients ... disorder that affects more than 3.5 million Americans and ... study on a novel application of this technology for ...
... expectation may be factors in helping older adults ... with the Birmingham Veterans Administration Medical Center and ... published in March in the Annals of ... for surgery returned to normal baseline function more ...
Cached Medicine News:Health News:Genetic risk factors play role in autoantibody-negative rheumatoid arthritis 2Health News:Laser Spine Institute Helps Professionals Take Back Their Lives from Debilitating Back Pain 2Health News:Laser Spine Institute Helps Professionals Take Back Their Lives from Debilitating Back Pain 3Health News:The National PKU Alliance Expands Leadership and Names Christine Brown as Executive Director 2Health News:The National PKU Alliance Expands Leadership and Names Christine Brown as Executive Director 3Health News:Parents Worry That 'Alcopops' Encourage Teen Drinking 2Health News:U study shows MRI-based method holds promise for predicting treatment outcomes in patients with AF 2Health News:VA/UAB study looks at functional decline in older patients after hospitalization 2Health News:VA/UAB study looks at functional decline in older patients after hospitalization 3
... and best value in high performance electronic ... ultra lightweight design reduce hand fatigue and ... lever tip ejector , Color coding for ... or for greater performance use Hamilton AdvanTip ...
... The Research pro Electronic Pipette is ideal ... laboratory. Its easy-to-follow display, ergonomically-placed operating buttons, ... dispensing, reverse pipetting and diluting make this ... simple functions of a manual pipette without ...
... Entire Column of a 384 Well Plate at ... 384 well plates, you need a pipettor that ... exactly what you get with our 16-channel Impact ... Impact/Impact2), this innovation was specifically designed to allow ...
... an Entire Column of a 384 Well Plate ... with 384 well plates, you need a pipettor ... Thats exactly what you get with our 16-channel ... (see Impact/Impact2), this innovation was specifically designed to ...
Medicine Products: